Industrialization and resource balance of Cordyceps sinensis

Business club, September 13 news Cordyceps prices began to soar, from the "SARS" began In recent years, driven by profit seeking, Cordyceps sinensis wild resources have been plundered The protection of rare resources and the maximization of market value are like the two poles of the seesaw The balance between them is always the key that people can't weigh Last month, the State Food and Drug Administration issued the pilot work program of Cordyceps for health food (hereinafter referred to as the "program"), which requires the rational use of rare resources, strict monitoring of Cordyceps raw material sources, in order to protect Cordyceps resources, maximize its use value, and promote the quality and safety control level of health food High and establish rare resources for health food regulatory model to lay the foundation Yu Zhibin, deputy director of traditional Chinese Medicine Department of China Chamber of Commerce for the import and export of medical and health products, pointed out: "the introduction of the plan has a positive role in promoting the Cordyceps industry By setting access threshold, we can better strengthen the supervision of the whole process of processing and use In addition, at present, Cordyceps sinensis is more sold as raw medicinal materials After it is allowed to be made into health products, it can obviously extend the industrial chain and deeply tap the market value of Cordyceps sinensis " The pilot health food Cordyceps sinensis, ginseng and pilose antler are called "three treasures of traditional Chinese medicine" Because of its yin-yang double tonic, gentle and widely used, it also has the reputation of "king of 100 medicines" In recent years, people pay more and more attention to health, Cordyceps sinensis has been sought after by consumers, not only as traditional Chinese medicine for disease treatment Song Minxian, director of the law and regulation department of Sichuan food and Drug Administration and professor of Chengdu University of traditional Chinese medicine, said in an interview with the author: "although Cordyceps has been excluded from the scope of health food, people who eat Cordyceps are not new People who have health care function often buy Cordyceps as food, for example, Guangdong region is often used to cook soup " The author understands that this is the first time for the state to strictly regulate the health food with Cordyceps sinensis as the main raw material, which means that the regulatory authorities will open up the use of Cordyceps sinensis for health food, in order to protect the development of rare medicinal resources, is an active exploration of the rational development of rare Chinese herbal resources, and encourages qualified enterprises to carry out the research of high value-added products So as to further release its market value Some insiders believe that the plan shows the government's support attitude for the sustainable utilization and development of the wild Cordyceps industry, which will boost the whole Cordyceps industry in the medium and long term The relevant requirements for the pilot are conducive to the standardized management of Cordyceps sinensis enterprises and the healthy development of the whole industry in the future However, the entry threshold of the scheme for pilot enterprises is quite high One of the conditions is that the annual sales of health food is more than 1 billion yuan Experts believe that the scheme will also speed up the reshuffle of the industry by raising the entry threshold of enterprises In the future, at least 30% of Cordyceps health products enterprises will be eliminated Once the pilot promotion method is successful, it also provides reference for the development and protection of other rare medicinal materials, but the premise is that it must be based on the perfect standard research It is reported that Qizheng Tibetan medicine, which previously could only manage Cordyceps, is actively applying for pilot The relevant director of Qizheng Tibetan medicine department said that Cordyceps sinensis accounted for more than 20% of the whole business of the company With the help of this policy, the company will gradually extend from the operation of Cordyceps sinensis to the deep processing of health products, which is expected to improve the performance of the company in the future It is worth noting that the quality of the original medicinal materials can be identified by many sensory indicators, but after the health products are made, due to no shape limitation, they only rely on some current technical indicators for detection "For example, adenosine mentioned in the pharmacopoeia is difficult to distinguish whether the source is real Cordyceps or mycelium fermentation." "This will leave room for illegal enterprises to make counterfeits," Yu reminded "For Cordyceps, a precious medicinal material, the current standard is difficult to deal with the problem of counterfeiting and illegal addition." Encountering the resource bottleneck, Cordyceps sinensis was listed as a national second-class protected species, which used to be one of the raw materials of health food Later, because of the scarcity of resources, the Ministry of health banned the use of Cordyceps sinensis in health food, replacing it with Paecilomyces batmoth "In recent years, the output of Cordyceps sinensis is still decreasing, and resource protection is quite difficult." Song Minxian pointed out that due to the harsh and scattered growth conditions, it is mainly relying on local farmers to collect medicine, which is difficult for the government and enterprises to supervise and control "At present, the resource status of Cordyceps sinensis in China is difficult to count, because it is not fixed every year due to various factors such as weather, mining time, etc." Yu said With the decrease of resources, the value of Cordyceps sinensis is increasing Now, the first-class grass is sold to 120000 yuan / Jin, the second-class grass is sold to 80000 yuan / Jin, and the third-class grass is sold to 65000 yuan / Jin According to the report on agricultural work issued by the government of Tibet Autonomous Region in 2011, compared with 2010, the output of Cordyceps sinensis in Tibet decreased by about 5% and the price increased by about 15% in 2011 The decrease of production leads to the decrease of export According to the statistics of China Chamber of Commerce for the import and export of medical and health products, the export volume of Cordyceps sinensis in 2011 was 1255kg, down 44.25% year on year; the export volume was US $28.3046 million, down 27.85% year on year While the export volume of Cordyceps decreased significantly in 2011, the export price reached US $22553.49 / kg, up 29.40% year on year The main reason is that the production of Cordyceps decreased last year due to climate factors, and the over collection of Cordyceps species resources is also seriously threatened Due to the lack of understanding of the rational development and utilization of traditional Chinese medicine resources, combined with predatory management and utilization, the resources of traditional Chinese medicine are facing atrophy and depletion, which seriously threatens the biodiversity of resources Therefore, it is of great practical significance to carry out the research on the sustainable utilization and in-depth development of precious traditional Chinese medicine resources and realize the maximization of the market value of medicinal resources Zhan ruotang, director of the research center of traditional Chinese medicine resources science and engineering, Guangzhou University of traditional Chinese medicine, made an analysis The above experts said that with the new understanding of the protection of rare resources, efforts should be made to effectively develop and utilize Cordyceps resources on the premise of reasonable protection of Cordyceps resources, and promote the research and development of high-end science and technology content health food Highlighting brand value "in industries with a large profit margin, when brand and scale benefits are not obvious, the threshold to enter this industry is very low, which is easy to cause low-level competition." Some experts think so At present, the adulteration of Cordyceps sinensis is common, such as adding lead powder and wire to increase the weight of Cordyceps sinensis, using Cordyceps militaris to fake Therefore, it is more important for Cordyceps industry to build a strong industry brand through brand integration, so as to promote the healthy development of Cordyceps industry After the brand is mature, enterprises can obtain higher added value of products by launching a series of products, and consumers can also get high-quality products with guaranteed quality, so that the market of Cordyceps sinensis can develop in a virtuous circle The requirements of the plan for pilot enterprises are "industry driven", which stipulates that the market share of relevant products of pilot enterprises should be at the forefront of the country, have greater influence, and have well-known trademarks in China It is understood that Sanjiangyuan pharmaceutical, which has been operating wild Cordyceps sinensis for many years, is on the way of earning market by means of reputation, extending its business scope from Cordyceps to its derivatives and expanding its business scope It has newly developed products including Cordyceps Yifei capsule, Cordyceps Oral Liquid and so on, and is actively marching towards the international market with high requirements for health products However, at present, the main source of Cordyceps sinensis in most enterprises is still acquired by acquisition "Artificial cultivation of Cordyceps sinensis is mainly difficult to make breakthroughs in planting and technology It was pointed out by the Song Dynasty people 's constitution The current situation is mainly wild and local farmers planting, but also lack of large-scale artificial planting, which requires enterprises to actively explore appropriate models In order to ensure the quality and solve the resource problem, Taiji Group has tried first In 2002, Taiji group and Chongqing Institute of traditional Chinese medicine jointly established Kangding zhongzang pharmaceutical science and Technology Co., Ltd., while Chongqing Institute of traditional Chinese medicine has been continuously carrying out research on Cordyceps propagation in yajiageng, 3800 meters above sea level, Yulin Township, Kangding since the end of 1970s In 2003, Taiji Group built Kangding Cordyceps planting base, which is reported to grow up to 1 square meter in the base Six Cordyceps have been produced, but the stage of industrialization and promotion still needs time "It seems that protection and development are contradictory In fact, as long as we keep a good balance, we can not only improve the ecological environment, but also develop and utilize resources Only through the investment of scientific research and brand building, and promoting artificial cultivation and breeding to replace wild resources, can we maximize the use value of medicinal materials resources " Yu concluded.